On September 27, 2024, at 1:01 PM EST, Concord Medical Services (CCM, Financial) experienced a sharp decline, with its stock price dropping by 5.31%. As of the latest update, CCM is trading at $6.15 per share with a volume of 121 shares and a turnover rate of 0.00%, showing no fluctuation.
Recent financial reports reveal that the company generated a revenue of $75.85 million, but reported a net loss of $42.01 million. The earnings per share (EPS) stand at -$9.62, with a gross profit of -$10.81 million and a price-earnings (P/E) ratio of -0.64. Currently, there are no institutional ratings for buy, hold, or sell recommendations on the stock.
In the broader healthcare facilities sector, the overall decline is noted at 0.55%. Notable gains in related stocks included P3 Health Partners Inc C/Wts 19/11/2026 (To Pur Com), Modivcare Inc., and Guardian Pharmacy Services, Inc. Active stocks in the sector include Arcadia Healthcare, Modivcare Inc., and Cross Country Healthcare, Inc. with turnover rates of 7.68%, 3.94%, and 3.22%, respectively. Stocks with significant fluctuations are P3 Health Partners Inc C/Wts 19/11/2026 (To Pur Com), Modivcare Inc., and Kindly Md, Inc., with amplitude rates of 68.77%, 17.65%, and 15.85%, respectively.
Concord Medical Services operates radiotherapy and diagnostic imaging centers across various provinces and administrative regions in China. The company's network includes centers specializing in radiotherapy, diagnostic imaging, and other therapeutic and diagnostic services. These services encompass EEG for epilepsy diagnosis, thermotherapy for enhancing radiotherapy and chemotherapy efficacy, high-intensity focused ultrasound (HIFU) for cancer treatment, stereotactic radiofrequency ablation for Parkinson's disease, and diagnostic measures for eye diseases.
